Boehringer Ingelheim is actively investing in AI technology, recognizing its potential to transform the biopharmaceutical industry. The company emphasizes the importance of a robust data environment for successful AI adoption and organizational change. Their internal data ecosystem, Dataland, plays a vital role in aggregating and analyzing information efficiently across the enterprise. Business leaders from Boehringer highlight best practices for AI integration, advocating for proper data management and leveraging advanced analytics to drive meaningful transformations in healthcare solutions.
To be able to execute use cases and analytics, you need a successful data environment, so we created that.
AI together with big data availability and access to the right capability is the real game-changer.
Collection
[
|
...
]